Second, the association between RSPO2 expression and clinical pathologic features of individuals could not be analyzed owing to the unavailability of sufficient paired ovarian tumor samples, and exploration with a large sample size is needed to further support this finding. This evidence concerns the gene RSPO2 and ovarian neoplasm.